152 related articles for article (PubMed ID: 23507839)
1. Deregulation of epigenetic mechanisms by the hepatitis B virus X protein in hepatocarcinogenesis.
Andrisani OM
Viruses; 2013 Mar; 5(3):858-72. PubMed ID: 23507839
[TBL] [Abstract][Full Text] [Related]
2. Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis.
Ebert G; Allison C; Preston S; Cooney J; Toe JG; Stutz MD; Ojaimi S; Baschuk N; Nachbur U; Torresi J; Silke J; Begley CG; Pellegrini M
Proc Natl Acad Sci U S A; 2015 May; 112(18):5803-8. PubMed ID: 25902530
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis.
Rongrui L; Na H; Zongfang L; Fanpu J; Shiwen J
Curr Pharm Des; 2014; 20(11):1715-25. PubMed ID: 23888939
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis.
Tian Y; Yang W; Song J; Wu Y; Ni B
Mol Cell Biol; 2013 Aug; 33(15):2810-6. PubMed ID: 23716588
[TBL] [Abstract][Full Text] [Related]
5. HAT1 signaling confers to assembly and epigenetic regulation of HBV cccDNA minichromosome.
Yang G; Feng J; Liu Y; Zhao M; Yuan Y; Yuan H; Yun H; Sun M; Bu Y; Liu L; Liu Z; Niu JQ; Yin M; Song X; Miao Z; Lin Z; Zhang X
Theranostics; 2019; 9(24):7345-7358. PubMed ID: 31695772
[No Abstract] [Full Text] [Related]
6. The interactions between PML nuclear bodies and small and medium size DNA viruses.
Ryabchenko B; Šroller V; Horníková L; Lovtsov A; Forstová J; Huérfano S
Virol J; 2023 May; 20(1):82. PubMed ID: 37127643
[TBL] [Abstract][Full Text] [Related]
7. Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis.
Soliman SHA; Orlacchio A; Verginelli F
Microorganisms; 2021 May; 9(6):. PubMed ID: 34070716
[TBL] [Abstract][Full Text] [Related]
8. cccDNA Maintenance in Chronic Hepatitis B - Targeting the Matrix of Viral Replication.
Dandri M; Petersen J
Infect Drug Resist; 2020; 13():3873-3886. PubMed ID: 33149632
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modulation in chronic hepatitis B virus infection.
Dandri M
Semin Immunopathol; 2020 Apr; 42(2):173-185. PubMed ID: 32185454
[TBL] [Abstract][Full Text] [Related]
10. Targeting Hepatitis B Virus Covalently Closed Circular DNA and Hepatitis B Virus X Protein: Recent Advances and New Approaches.
Prescott NA; Bram Y; Schwartz RE; David Y
ACS Infect Dis; 2019 Oct; 5(10):1657-1667. PubMed ID: 31525994
[TBL] [Abstract][Full Text] [Related]
11. The Down-Regulation of SUZ12 Accelerates the Migration and Invasion of Liver Cancer Cells via Activating ERK1/2 Pathway.
Xue C; Wang K; Jiang X; Gu C; Yu G; Zhong Y; Liu S; Nie Y; Zhou Y; Yang H
J Cancer; 2019; 10(6):1375-1384. PubMed ID: 31031847
[TBL] [Abstract][Full Text] [Related]
12. Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner.
Saeed U; Kim J; Piracha ZZ; Kwon H; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567987
[TBL] [Abstract][Full Text] [Related]
13. Towards the development of activity-based probes for detection of lysine-specific demethylase-1 activity.
Ourailidou ME; Lenoci A; Zwergel C; Rotili D; Mai A; Dekker FJ
Bioorg Med Chem; 2017 Feb; 25(3):847-856. PubMed ID: 27989416
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein influences enrichment profiles of H3K9me3 on promoter regions in human hepatoma cell lines.
Wang DY; An SH; Liu L; Bai SS; Wu KX; Zhu R; Wang ZJ
Oncotarget; 2016 Dec; 7(51):84883-84892. PubMed ID: 27768594
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics and Genetics of Viral Latency.
Lieberman PM
Cell Host Microbe; 2016 May; 19(5):619-28. PubMed ID: 27173930
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Virus X and Regulation of Viral Gene Expression.
Slagle BL; Bouchard MJ
Cold Spring Harb Perspect Med; 2016 Jan; 6(3):a021402. PubMed ID: 26747833
[TBL] [Abstract][Full Text] [Related]
17. Chemokine Expression Profiles of Human Hepatoma Cell Lines Mediated by Hepatitis B Virus X Protein.
Wang DY; Zou LP; Liu XJ; Zhu HG; Zhu R
Pathol Oncol Res; 2016 Apr; 22(2):393-9. PubMed ID: 26581611
[TBL] [Abstract][Full Text] [Related]
18. Pure Diastereomers of a Tranylcypromine-Based LSD1 Inhibitor: Enzyme Selectivity and In-Cell Studies.
Valente S; Rodriguez V; Mercurio C; Vianello P; Saponara B; Cirilli R; Ciossani G; Labella D; Marrocco B; Ruoppolo G; Botrugno OA; Dessanti P; Minucci S; Mattevi A; Varasi M; Mai A
ACS Med Chem Lett; 2015 Feb; 6(2):173-7. PubMed ID: 25699146
[TBL] [Abstract][Full Text] [Related]
19. How did hepatitis B virus effect the host genome in the last decade?
Ozkal-Baydin P
World J Hepatol; 2014 Dec; 6(12):851-9. PubMed ID: 25544872
[TBL] [Abstract][Full Text] [Related]
20. Technical standards for hepatitis B virus X protein (HBx) research.
Slagle BL; Andrisani OM; Bouchard MJ; Lee CG; Ou JH; Siddiqui A
Hepatology; 2015 Apr; 61(4):1416-24. PubMed ID: 25099228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]